Business Context and Reporting Period
Company: CALIX, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: April 18, 2025
Event: Amendment to the Company's common stock repurchase program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt figures. The only financial metric disclosed relates to capital allocation:
- Remaining Authorized Balance (as of March 29, 2025): $62.9 million
- Additional Authorization (April 18, 2025): $100 million
- Total Program Authorization (Post-Amendment): $300 million
Material Changes
On April 18, 2025, the Board of Directors amended the existing stock repurchase program to increase the total authorization by $100 million. This action raises the total authorized amount to $300 million. The filing does not disclose any changes to operational performance or financial results compared to prior periods.
Guidance, Outlook, and Management Commentary
Repurchase Program Details:
- Methods: Purchases may be made via open market, privately negotiated transactions, or other methods compliant with SEC rules.
- Timing and Size: Dependent on prevailing stock prices, economic conditions, and capital allocation strategy.
- Obligation: The program does not obligate the Company to acquire a specific amount of stock.
- Flexibility: The program may be suspended or discontinued at any time at the Company's discretion.
Investor Verification Checklist
- Verify the exact date the $100 million increase was approved by the Board (April 18, 2025).
- Confirm the total remaining authorization is now $300 million.
- Review the attached Press Release (Exhibit 99.1) for any additional commentary on capital allocation strategy.
- Note that no specific timeline or volume for future repurchases is guaranteed.